Transanal Irrigation Improves LARS Outcomes : BJS | May 2026

Introduction

Low Anterior Resection Syndrome is a major long-term complication following sphincter-preserving rectal cancer surgery and is characterized by fecal urgency, incontinence, clustering, fragmentation and impaired quality of life. Despite its substantial functional burden, effective long-term treatment strategies remain limited.

Problem Statement

Evidence supporting the use of Transanal Irrigation for severe low anterior resection syndrome remains limited, particularly from randomized multicenter studies evaluating long-term feasibility, bowel function and quality-of-life outcomes.

Summary

This international multicenter randomized clinical trial evaluated transanal irrigation versus best supportive care in patients with major low anterior resection syndrome persisting at least one year after rectal surgery.

The study demonstrated substantial improvement in bowel function among patients treated with transanal irrigation. At 12 months, patients receiving irrigation showed dramatically lower LARS and Wexner incontinence scores compared with standard supportive management, indicating clinically meaningful improvement in continence and bowel control.

Importantly, the benefits extended beyond symptom scores alone. Patients undergoing transanal irrigation also achieved significantly better quality-of-life outcomes and higher bowel function instrument scores, reinforcing the broader functional and psychosocial impact of improved bowel regulation.

A notable strength of the study was the high treatment adherence observed throughout follow-up. Three-quarters of patients continued daily irrigation at 12 months, suggesting that transanal irrigation is not only effective but also practically acceptable for long-term use in motivated patients.

The safety profile was favorable, with only minor procedure-related adverse events reported. No major complications were observed, supporting the relative procedural safety of structured irrigation protocols in experienced settings.

The findings are clinically important because LARS remains one of the most underrecognized survivorship complications following rectal cancer treatment. While oncologic outcomes have improved substantially with sphincter-preserving surgery, many patients continue to experience severe functional disability despite technically successful resections.

The study also reinforces the concept that bowel dysfunction after rectal surgery should be approached proactively rather than accepted as an unavoidable postoperative consequence. Structured rehabilitation strategies may significantly improve long-term survivorship quality.

Mechanistically, transanal irrigation likely improves symptoms by facilitating predictable bowel emptying, reducing stool fragmentation and minimizing urgency episodes. This restoration of bowel control may substantially reduce anxiety and social limitation associated with unpredictable defecation patterns.

The trial further highlights the need for dedicated multidisciplinary LARS pathways integrating colorectal surgeons, gastroenterologists, pelvic floor specialists and continence teams. Early identification and escalation to advanced supportive therapies may prevent chronic deterioration in quality of life.

Although the study size was modest, the magnitude and consistency of benefit across multiple functional endpoints provide strong support for transanal irrigation as an important therapeutic option in severe LARS.

Future work will need to better define optimal patient selection, timing of initiation, long-term durability and integration with other rehabilitative approaches including pelvic floor therapy, neuromodulation and dietary interventions.

Overall, this randomized multicenter trial demonstrates that transanal irrigation is feasible, safe and highly effective for severe low anterior resection syndrome, producing substantial improvements in bowel function, continence and quality of life compared with best supportive care.